Dr. Rosenberg our Head of Clinical Affairs has deep experience in drug development and medical affairs in multiple therapeutic areas including CV/metabolic. He has led several successful drug submission teams both in the US and globally, and launched multiple drugs.  He achieved his BA, MD and residency completion at The Johns Hopkins University, Drexel University and Mount Sinai School of Medicine at New York University, respectively. He has 20+ years of biotech/pharma experience in both large (Pfizer, Sanofi, Forest labs) and small (Travere, Esperion) pharmaceutical companies. Currently, he is a principal at BHCC and provides clinical consulting to biotech and pharma.